Kubouchi Yasuaki, Wada Toho, Yasuda Ryota, Nozaka Yuji, Fujiwara Wakako, Matsui Shinji, Tanaka Yugo
Faculty of Medicine, Division of General Thoracic Surgery and Breast and Endocrine Surgery, Department of Surgery, Tottori University, 36-1, Nishi-Cho, Yonago, Tottori, 683-8503, Japan.
Surg Today. 2025 Aug 21. doi: 10.1007/s00595-025-03119-6.
Spread through air spaces (STAS) is a poor prognostic factor for lung adenocarcinoma, particularly in patients undergoing limited resection, and its accurate prediction can improve the patient outcomes. This study evaluated the impact of STAS on the surgical outcomes and predictive factors.
We analyzed 511 patients with clinical stage IA lung adenocarcinoma who underwent curative resection between 2007 and 2022. STAS was assessed histologically, and logistic regression was used to identify the predictors. The recurrence-free and overall survival rates were also evaluated.
Among the patients, 27.8% had STAS with significantly poor 5-year recurrence-free survival (65.6% vs. 88.5% in STAS-positive vs.-negative cases, respectively), particularly in patients treated with sublobar resection. STAS was an independent, poor prognostic factor for the recurrence-free survival in the sublobar group but not in the lobectomy group. Elevated serum carcinoembryonic antigen (≥ 5.8 ng/mL), consolidation tumor ratio (≥ 0.9), and SUVmax (≥ 2.3) were independent predictors. STAS positivity increased with the number of risk factors as follows: 8.0% (none), 27.1% (one), 38.5% (two), and 60.4% (all three).
The prediction of STAS using carcinoembryonic antigen levels, consolidation tumor ratio, and SUVmax can guide surgical decision-making and facilitate the provision of individualized treatment strategies for stage IA lung adenocarcinoma.
气腔播散(STAS)是肺腺癌的一个不良预后因素,尤其是在接受有限切除的患者中,准确预测STAS可改善患者预后。本研究评估了STAS对手术结局的影响及预测因素。
我们分析了2007年至2022年间接受根治性切除的511例临床IA期肺腺癌患者。通过组织学评估STAS,并采用逻辑回归确定预测因素。还评估了无复发生存率和总生存率。
在这些患者中,27.8%存在STAS,其5年无复发生存率显著较差(STAS阳性组和阴性组分别为65.6%和88.5%),尤其是在接受亚肺叶切除的患者中。STAS是亚肺叶切除组无复发生存的独立不良预后因素,但在肺叶切除组中并非如此。血清癌胚抗原升高(≥5.8 ng/mL)、实性肿瘤比例(≥0.9)和最大标准摄取值(≥2.3)是独立的预测因素。STAS阳性率随危险因素数量增加如下:无危险因素为8.0%,一个危险因素为27.1%,两个危险因素为38.5%,三个危险因素均存在为60.4%。
利用癌胚抗原水平、实性肿瘤比例和最大标准摄取值预测STAS可指导手术决策,并有助于为IA期肺腺癌提供个体化治疗策略。